January/February 2018

The unrelenting growth of diabetes around the world is prompting cardiologists to rethink how they treat and manage a challenging patient population, even as an emerging class of cardio-protective diabetes drugs is setting the stage for transformation.

When third-grader Ava Rao was diagnosed with type 1 diabetes, it changed life for her whole family. Now a high school freshman, Ava and her dad, cardiologist Sunil V. Rao, MD, share their perspectives on the disease and hopes for the future. 

As Cardiovascular Business enters its second decade, our team has been pondering what the magazine’s pre-teen and teen years will be like. Are we looking at dignified maturity or awkward adolescence? 

Cardiologists are receiving more exposure to different imaging modalities during their fellowships, but their job prospects and training vary widely. A more comprehensive and multimodality training approach could lead to better results.  

Concierge cardiologists report high job satisfaction along with more stable practice revenue, but experts caution specialists to learn about the differences in practice models.   

Understanding risks, policy costs and potential value can help you decide whether to invest in cyber-liability insurance.

Artificial intelligence (AI)–assisted electrophysiology (EP) shows promise, but even its most ardent advocates aren’t ready for full-fledged endorsement—yet.   

Daniel A.jpg

Ensuring mission and money in faculty compensation plans is a tall order for academic medical centers.

The healthcare delivery environment continues to evolve, requiring clinicians and practice executives to seek solutions that will lead to a pathway of success.

Patients want healthcare cost information, but price lists alone aren’t turning them into savvy shoppers.

Conversations about compensation are among the toughest for healthcare leaders to navigate. Add accusations of gender bias, and it’s a powder keg.

Select an Issue
CVB